WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 585316
CAS#: 141490-47-3
Description: U46,195 stimulates the production of tissue-type plasminogen activator, and is a PAF antagonist.
MedKoo Cat#: 585316
Name: U46,195
CAS#: 141490-47-3
Chemical Formula: C17H13ClN4O
Exact Mass: 324.0778
Molecular Weight: 324.768
Elemental Analysis: C, 62.87; H, 4.03; Cl, 10.92; N, 17.25; O, 4.93
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: U46,195; U 46,195; U-46,195; U 46195; U46195; U-46195
IUPAC/Chemical Name: 3-(8-chloro-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-6-yl)phenol
InChi Key: GGQZNQSJWZEGBR-UHFFFAOYSA-N
InChi Code: InChI=1S/C17H13ClN4O/c1-10-20-21-16-9-19-17(11-3-2-4-13(23)7-11)14-8-12(18)5-6-15(14)22(10)16/h2-8,23H,9H2,1H3
SMILES Code: OC1=CC=CC(C2=NCC3=NN=C(C)N3C4=CC=C(Cl)C=C24)=C1
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 324.768 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
1: Torr SR, Haskel EJ, VonVoigtlander PF, Bergmann SR, Abendschein DR. Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor. J Am Coll Cardiol. 1991 Dec;18(7):1804-10. PubMed PMID: 1960333.
2: Kooistra T, Toet K, Kluft C, VonVoigtlander PF, Ennis MD, Aiken JW, Boadt JA, Erickson LA. Triazolobenzodiazepines: a new class of stimulators of tissue-type plasminogen activator synthesis in human endothelial cells. Biochem Pharmacol. 1993 Jul 6;46(1):61-7. PubMed PMID: 8347138.
